Prof Crispin Miller
Computational Biology
As biology becomes increasingly data rich, the need for computational biology has grown rapidly. This leads to significant challenges, both in terms of providing the infrastructure to support the data management and analysis, and in terms of analysing the complex multimodal ‘deep phenotyping’ datasets we are generating.

Biography

Recent Publications
Biography
Education and qualifications
- 2000: PhD, Bioinformatics, The University of Manchester
- 1996: BSc, Artificial Intelligence, The University of Manchester
Appointments
- 2019–: Head of Bioinformatics, Cancer Research UK Scotland Institute
- 2012–2018: Senior Group Leader, Cancer Research UK Manchester Institute
- 2007–2012: Senior Staff Scientist, The Paterson Institute for Cancer Research, The University of Manchester
- 2002–2007: Junior Group Leader, The Paterson Institute for Cancer Research, The University of Manchester
- 2000–2002: MRC Fellowship, The University of Manchester
Funding
- NC3R’s
Recent Publications
2026
White M., Mills M.L., Millett L.M., Gilroy K., Hong Y., Zeiger L.B., Simpson R.J., Corry S.M., Ligeza A., Lannagan T.R.M., Susanti S., Ridgway R.A., Yazgili A.S., Grzesiak L., Amirkhah R., Ford C.A., Vlahov N., Tovell H., Officer-Jones L., Ficken C., Pennie R., Najumudeen A.K., Raven A., Nasreddin N., Chauhan E., Papanastasiou A.S., Nixon C., Morrison V., Jackstadt R., Graham J.S., Miller C.J., Ross S.J., Barry S.T., Pavet V., Wilson R.H., Le Quesne J., Dunne P.D., Tejpar S., Leedham S., Campbell A.D., Sansom O.J. MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance (2026) Nature, 650 (8102), pp. 748 – 758 DOI: 10.1038/s41586-025-09916-w
Raven A., Gilroy K., Jin H., Waldron J.A., Leslie H., Munro J., Hall H., Ridgway R.A., Ford C.A., Gulhan D.C., Vlahov N., Mills M.L., Hartley A., Anderson E., Bryson S., Sphyris N., Müller M., May S., Cadden B., Nixon C., Waddell S.H., Guest R., Boulter L., Barker N., Clevers H., Zhu H., Ivaska J., Strathdee D., Miller C.J., Jamieson N.B., Bushell M., Park P.J., Bird T.G., Sansom O.J. Hepatic zonation determines tumorigenic potential of mutant β-catenin (2026) Nature, 649 (8097), pp. 739 – 748 DOI: 10.1038/s41586-025-09733-1
Kanellos G., Giacomelli C., Raven A., Vlahov N., Jin H., Herviou P., Malla S.B., Nasreddin N., Centeno P.P., Alexandrou C., Gilroy K., Baird R.L., Pennel K., Munro J., Waldron J.A., Hall H., Officer-Jones L., Bryson S., Strathdee D., Lilla S., Zanivan S., Morrison V., Nixon C., Ridgway R.A., Miller C., Knight J.R.P., Campbell A.D., Dunne P.D., Le Quesne J., Edwards J., Park P.J., Bushell M., Sansom O.J. Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation (2026) Nature Genetics, 58 (1), pp. 100 – 115 DOI: 10.1038/s41588-025-02408-7
Riggio A.I., Sweeney K., Shaw R., Lawlor A., Khan A., Ferrari N., Anand J., Galbraith L.C.A., Gilroy K., Bull C., Young A.L., Athineos D., Hall H., Ghaffar F., Hughes M., Mitchell C.A., Mitchell L., Nixon C., Adams P.D., Roberts E.W., Miller C.J., Dunne P.D., Campbell K.J., Cameron E.R., Blyth K. Runx1 and Runx2 act in concert to suppress Wnt/β-catenin-driven mammary tumourigenesis (2026) British Journal of Cancer, 135 (4), pp. 532 – 545 DOI: 10.1038/s41416-026-03439-5
Müller M., May S., Hall H., Kendall T.J., McGarry L., Blukacz L., Nuciforo S., Georgakopoulou A., Jamieson T., Phinichkusolchit N., Dhayade S., Suzuki T., Huguet-Pradell J., Powley I.R., Officer-Jones L., Pennie R.L., Esteban-Fabró R., Gris-Oliver A., Pinyol R., Skalka G.L., Leslie J., Hoare M., Sprangers J., Malviya G., Mackintosh A., Johnson E., McCain M., Halpin J., Kiourtis C., Nixon C., Clark G., Clark W., Shaw R., Hedley A., Drake T.M., Tan E.H., Neilson M., Murphy D.J., Lewis D.Y., Reeves H.L., Le Quesne J., Mann D.A., Carlin L.M., Blyth K., Llovet J.M., Heim M.H., Sansom O.J., Miller C.J., Bird T.G. Human-correlated genetic models identify precision therapy for liver cancer (2025) Nature, 639 (8055), pp. 754 – 764 DOI: 10.1038/s41586-025-08585-z
Liu D., Young F., Lamb K.D., Claudio Quiros A., Pancheva A., Miller C.J., Macdonald C., Robertson D.L., Yuan K. PLM-interact: extending protein language models to predict protein-protein interactions (2025) Nature Communications, 16 (1), art. no. 9012 DOI: 10.1038/s41467-025-64512-w
Malla S.B., Byrne R.M., Lafarge M.W., Corry S.M., Fisher N.C., Tsantoulis P.K., Mills M.L., Ridgway R.A., Lannagan T.R.M., Najumudeen A.K., Gilroy K.L., Amirkhah R., Maguire S.L., Mulholland E.J., Belnoue-Davis H.L., Grassi E., Viviani M., Rogan E., Redmond K.L., Sakhnevych S., McCooey A.J., Bull C., Hoey E., Sinevici N., Hall H., Ahmaderaghi B., Domingo E., Blake A., Richman S.D., Isella C., Miller C., Bertotti A., Trusolino L., Loughrey M.B., Kerr E.M., Tejpar S., Maughan T.S., Lawler M., Campbell A.D., Leedham S.J., Koelzer V.H., Sansom O.J., Dunne P.D. Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer (2024) Nature Genetics, 56 (3), pp. 458 – 472 DOI: 10.1038/s41588-024-01654-5
Wiesheu R., Edwards S.C., Hedley A., Hall H., Tosolini M., Fares da Silva M.G.F., Sumaria N., Castenmiller S.M., Wardak L., Optaczy Y., Lynn A., Hill D.G., Hayes A.J., Hay J., Kilbey A., Shaw R., Whyte D., Walsh P.J., Michie A.M., Graham G.J., Manoharan A., Halsey C., Blyth K., Wolkers M.C., Miller C., Pennington D.J., Jones G.W., Fournie J.-J., Bekiaris V., Coffelt S.B. IL-27 maintains cytotoxic Ly6C<sup>+</sup> γδ T cells that arise from immature precursors (2024) EMBO Journal, 43 (14), pp. 2878 – 2907 DOI: 10.1038/s44318-024-00133-1
Edwards S.C., Hedley A., Hoevenaar W.H.M., Wiesheu R., Glauner T., Kilbey A., Shaw R., Boufea K., Batada N., Hatano S., Yoshikai Y., Blyth K., Miller C., Kirschner K., Coffelt S.B. PD-1 and TIM-3 differentially regulate subsets of mouse IL-17A–producing γδ Tcells (2023) Journal of Experimental Medicine, 220 (2), art. no. e20211431 DOI: 10.1084/jem.20211431
Román-Fernández A., Mansour M.A., Kugeratski F.G., Anand J., Sandilands E., Galbraith L., Rakovic K., Freckmann E.C., Cumming E.M., Park J., Nikolatou K., Lilla S., Shaw R., Strachan D., Mason S., Patel R., McGarry L., Katoch A., Campbell K.J., Nixon C., Miller C.J., Leung H.Y., Le Quesne J., Norman J.C., Zanivan S., Blyth K., Bryant D.M. Spatial regulation of the glycocalyx component podocalyxin is a switch for prometastatic function (2023) Science Advances, 9 (5), art. no. eabq1858 DOI: 10.1126/sciadv.abq1858
Freckmann E.C., Sandilands E., Cumming E., Neilson M., Román-Fernández A., Nikolatou K., Nacke M., Lannagan O.J., Miller C.J., Bryant D.M. Traject3d allows label-free identification of distinct co-occurring phenotypes within 3D culture by live imaging (2022) Nature Communications, 13 (1), art. no. 5317 DOI: 10.1038/s41467-022-32958-x

